Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026) 8 - 10 September 2026

Baseline characteristics, treatment patterns and 12-month real-world effectiveness of somapacitan in patients with growth hormone deficiency (GHD): data from GloBE-Reg 

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Endocrine Disorder
Congress poster
Somapacitan